Literature DB >> 3945555

Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene.

D M Valenzuela, J Groffen.   

Abstract

We have used synthetic oligonucleotides to probe for mutations affecting amino acid 12 of the c-K-ras gene in human cell line DNA. Of seven carcinoma cell lines tested, four were found to contain a mutation at this position. In each the nucleotide G was replaced with an A resulting in a Gly to Asp substitution in three cases (cell lines A427, A1165 and A1663) and Gly to Ser in the fourth (A549). Neither of these substitutions have been previously reported in either human tumor or human tumor-derived cell line DNA's. These results indicate that association between mutations involving position 12 of the human c-K-ras oncogene and carcinomas may be stronger than previously recognized.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3945555      PMCID: PMC339468          DOI: 10.1093/nar/14.2.843

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  26 in total

1.  Mechanism of activation of a human oncogene.

Authors:  C J Tabin; S M Bradley; C I Bargmann; R A Weinberg; A G Papageorge; E M Scolnick; R Dhar; D R Lowy; E H Chang
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

2.  An activated rasN gene: detected in late but not early passage human PA1 teratocarcinoma cells.

Authors:  M A Tainsky; C S Cooper; B C Giovanella; G F Vande Woude
Journal:  Science       Date:  1984-08-10       Impact factor: 47.728

3.  A point mutation is responsible for the acquisition of transforming properties by the T24 human bladder carcinoma oncogene.

Authors:  E P Reddy; R K Reynolds; E Santos; M Barbacid
Journal:  Nature       Date:  1982-11-11       Impact factor: 49.962

4.  Oncogenes in solid human tumours.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; S A Aaronson; M Barbacid
Journal:  Nature       Date:  1982-12-09       Impact factor: 49.962

5.  Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid change.

Authors:  E Taparowsky; Y Suard; O Fasano; K Shimizu; M Goldfarb; M Wigler
Journal:  Nature       Date:  1982-12-23       Impact factor: 49.962

6.  Detection of sickle cell beta S-globin allele by hybridization with synthetic oligonucleotides.

Authors:  B J Conner; A A Reyes; C Morin; K Itakura; R L Teplitz; R B Wallace
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

7.  Oncogenes in human tumor cell lines: molecular cloning of a transforming gene from human bladder carcinoma cells.

Authors:  S Pulciani; E Santos; A V Lauver; L K Long; K C Robbins; M Barbacid
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

8.  A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient.

Authors:  M H Kraus; Y Yuasa; S A Aaronson
Journal:  Proc Natl Acad Sci U S A       Date:  1984-09       Impact factor: 11.205

9.  Human colon carcinoma Ki-ras2 oncogene and its corresponding proto-oncogene.

Authors:  M S McCoy; C I Bargmann; R A Weinberg
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

10.  Activation of a c-K-ras oncogene by somatic mutation in mouse lymphomas induced by gamma radiation.

Authors:  I Guerrero; A Villasante; V Corces; A Pellicer
Journal:  Science       Date:  1984-09-14       Impact factor: 47.728

View more
  29 in total

1.  The CRAL/TRIO and GOLD domain protein TAP-1 regulates RAF-1 activation.

Authors:  Kenneth G Johnson; Kerry Kornfeld
Journal:  Dev Biol       Date:  2010-03-15       Impact factor: 3.582

Review 2.  Invited contribution: an objective approach to the development of short-term tests predictive of carcinogenicity.

Authors:  H S Rosenkranz; F K Ennever; V Chankong; J Pet-Edwards; Y Y Haimes
Journal:  Cell Biol Toxicol       Date:  1986-12       Impact factor: 6.691

3.  Detection of ras oncogenes by analysis of p21 proteins in human tumor cell lines.

Authors:  J Fujita; O Yoshida; Y Ebi; H Nakayama; H Onoue; J S Rhim; Y Kitamura
Journal:  Urol Res       Date:  1988

Review 4.  Human cancer and cellular oncogenes.

Authors:  S Nishimura; T Sekiya
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

5.  Human cancers converge at the HIF-2alpha oncogenic axis.

Authors:  Aleksandra Franovic; Chet E Holterman; Josianne Payette; Stephen Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-02       Impact factor: 11.205

6.  K-ras mutations in sinonasal cancers in relation to wood dust exposure.

Authors:  Jette Bornholdt; Johnni Hansen; Torben Steiniche; Michael Dictor; Annemarie Antonsen; Henrik Wolff; Vivi Schlünssen; Reetta Holmila; Danièle Luce; Ulla Vogel; Kirsti Husgafvel-Pursiainen; Håkan Wallin
Journal:  BMC Cancer       Date:  2008-02-20       Impact factor: 4.430

7.  Targeted covalent inactivation of protein kinases by resorcylic acid lactone polyketides.

Authors:  Andreas Schirmer; Jonathan Kennedy; Sumati Murli; Ralph Reid; Daniel V Santi
Journal:  Proc Natl Acad Sci U S A       Date:  2006-03-06       Impact factor: 11.205

8.  Increased cell migration and plasticity in Nrf2-deficient cancer cell lines.

Authors:  G Rachakonda; K R Sekhar; D Jowhar; P C Samson; J P Wikswo; R D Beauchamp; P K Datta; M L Freeman
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

9.  Redox processes inform multivariate transdifferentiation trajectories associated with TGFβ-induced epithelial-mesenchymal transition.

Authors:  Adam F Prasanphanich; C Andrew Arencibia; Melissa L Kemp
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

10.  K-RAS mutation in transitional cell carcinoma of urinary bladder.

Authors:  S Ayan; G Gokce; H Kilicarslan; O Ozdemir; E Yildiz; E Y Gultekin
Journal:  Int Urol Nephrol       Date:  2001       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.